by Julie Grisham, MS, Freelance Science Writer Tuesday, May 27, 2014
David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.
by Eva Kiesler, PhD, Senior Science Writer/Editor Tuesday, May 20, 2014
With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.
by Media Staff, Department of Public Affairs Thursday, May 15, 2014
New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.